Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of TAF Used in Early and Middle Pregnancy With Chronic Hepatitis B: a Multicenter Prospective Cohort Study

NCT07668934 is registered in ClinicalTrials.gov with The Third Affiliated Hospital of Guangzhou Medical University as lead sponsor.

NCT NCT07668934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07668934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of TAF Used in Early and Middle Pregnancy With Chronic Hepatitis B: a Multicenter Prospective Cohort Study
Lead sponsor
The Third Affiliated Hospital of Guangzhou Medical University
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
March 31, 2025
Completion date
March 30, 2028
Enrollment
816 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early pregnancy, hepatitis b infection, pregnant women